PCM
TECH icon

Prelude Capital Management’s Bio-Techne TECH Stock Holding History

Prelude Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.48M Buy
+91,696
New +$4.95M 0.47% 35
2025
Q3 		– Sell
-9,530
Closed -$490K – 1379
2025
Q2 		$490K Buy
+9,530
New +$479K 0.05% 449
2024
Q4 		– Sell
-3,512
Closed -$281K – 1556
2024
Q3 		$281K Sell
3,512
-15,810
-82% -$1.19M 0.02% 898
2024
Q2 		$1.38M Sell
19,322
-6,554
-25% -$482K 0.1% 254
2024
Q1 		$1.82M Buy
25,876
+14,482
+127% +$1.04M 0.1% 257
2023
Q4 		$879K Buy
11,394
+4,603
+68% +$303K 0.06% 325
2023
Q3 		$462K Buy
+6,791
New +$536K 0.03% 494
2021
Q4 		– Sell
-4,356
Closed -$528K – 2243
2021
Q3 		$528K Buy
+4,356
New +$530K 0.01% 864
2021
Q1 		– Sell
-6,104
Closed -$485K – 1808
2020
Q4 		$485K Buy
+6,104
New +$442K 0.01% 731
2018
Q3 		– Sell
-800
Closed -$30K – 2028
2018
Q2 		$30K Buy
+800
New +$30.5K ﹤0.01% 1259
2017
Q4 		– Sell
-10,320
Closed -$312K – 1705
2017
Q3 		$312K Buy
10,320
+1,872
+22% +$55.6K 0.03% 507
2017
Q2 		$248K Buy
8,448
+6,684
+379% +$183K 0.02% 516
2017
Q1 		$45K Buy
+1,764
New +$45.5K ﹤0.01% 1030
2015
Q2 		– Sell
-3,212
Closed -$81K – 2026
2015
Q1 		$81K Buy
+3,212
New +$76.4K 0.01% 1097
2014
Q4 		– Sell
-18,248
Closed -$427K – 2144
2014
Q3 		$427K Buy
18,248
+4,460
+32% +$105K 0.06% 424
2014
Q2 		$319K Sell
13,788
-17,248
-56% -$381K 0.04% 537
2014
Q1 		$662K Buy
+31,036
New +$698K 0.09% 306
2013
Q4 		– Sell
-120
Closed -$2K – 1905
2013
Q3 		$2K Buy
+120
New +$2.28K ﹤0.01% 1682

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Prelude Capital Management's TECH Position: Q2 2026 in Review

Prelude Capital Management opened a new position in Bio-Techne (TECH) in Q2 2026: 91,696 shares worth $6.48M. The stake represents 0.47% of the portfolio and ranks #35 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in TECH as recently as Q2 2025.

Prelude Capital Management first reported a position in TECH in Q3 2013 and has held it in 18 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Prelude Capital Management held 91,696 shares of Bio-Techne worth $6.48M as of Q2 2026.
  • Bio-Techne was a new Prelude Capital Management position in Q2 2026.
  • Bio-Techne made up 0.47% of Prelude Capital Management's portfolio in Q2 2026, its #35 holding.
  • Prelude Capital Management first reported a position in Bio-Techne in Q3 2013 and has held it in 18 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.